Europe — EMA

Paliperidon Stada (Paliperidone)

Request sourcing

Pack/s

What is Paliperidone?

Paliperidone, the active ingredient in Paliperidon Stada, is an antipsychotic presented as a unknown/unknown for intramuscular use. It is used in the management of schizophrenia and related psychotic disorders in adults. GNH USA supplies Paliperidon Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidon Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Paliperidone used for?

Paliperidone is indicated for the treatment of psychotic disorders within the schizophrenia spectrum.

- Schizophrenia: Reduces the frequency and severity of hallucinations, delusions and thought disorder. - Schizoaffective disorder: Helps stabilize mood and psychotic symptoms. - Bipolar I disorder (as adjunctive therapy): Contributes to mood stabilization. - Acute psychotic episodes: Provides rapid symptom control. - Maintenance therapy: Supports long‑term relapse prevention. - Long‑acting injection (LAI) formulation: Offers sustained drug delivery over weeks.

What are the side effects of Paliperidone?

Paliperidone may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Ak Ak. - - ewline - ewline - ewline - ewline - ewline Serious or Rare t

t t.

What precautions apply to Paliperidone?

Pal- n .

ewline .

t ewline ewline .

t ewline .

ewline .

ewline

ewline " ".

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →